Sales, Elizabeth D.

HRN: 24-55-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/19/2025
07/26/2025
IV
600mg
Q6hr
Abscess Formation
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines